International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 14 Issue 4, October - December, Pages:1-6

Correlation of Hypovitaminosis D with Decompensated Chronic Liver Disease: A Cross-Sectional Study

Dr. R. K. Patel, Dr. D. P. Lakra, Dr. C. S. Sharma and Dr. Gurkirat Arora
DOI: http://dx.doi.org/10.22376/ijpbs.2023.14.4.p1-6
Abstract:

Hypovitaminosis D, an insufficiency or deficiency of vitamin D, can affect men and women across the lifespan. This fat-soluble vitamin affects mineral metabolism and numerous other physiologic functions. Chronic liver diseases (CLD) cause significant morbidity and mortality worldwide. The use of a biomarker such as 25-hydroxyvitamin D, indicates the severity of the disease, its complications and serves as a tool for early intervention. The present study was conducted with an objective to study the correlation of hypovitaminosis D in Decompensated Chronic Liver Disease and its clinical significance in Tertiary Care Hospital. The present study was an observational cross-sectional study carried out at the Department of Medicine of the tertiary care centre during November 2021 to October 2022. A total sample size of 60 patients with decompensated Chronic Liver Disease admitted in hospital was included in the study population. Vitamin D insufficiency is defined as 25 (OH) D level below 75 nmol/L (30 ng/mL) and deficiency as levels below 50 nmol/L (20 ng/mL). The outcome variables included levels of hypovitaminosis D in chronic liver disease patients, MELD score and Child Pugh Score. The statistical software namely SPSS 22.0 used for the analysis of the data. The mean age of the study population was 45.03 ±10.94 years. Majority of the patients were males (86.67%) Majority of patients with liver disease were with Vitamin D deficiency (76.67%) MELD score increases with vitamin deficiency and shows significant statistical association.  The correlation of Vitamin D with MELD score and Child Pugh score shows significant strong negative correlation. This study was concluding that the Hypovitaminosis D is prevalent in chronic liver disease. CLD is associated with a significantly low level of vitamin D which was independent to gender.

Keywords: Correlation, Hypovitaminosis D, Decompensated Chronic Liver Disease, MELD Score, Child Pugh Score.
Full HTML:

References

  1. Pérez-López FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas. 2007;58(2):117-37. doi: 10.1016/j.maturitas.2007.05.002, PMID 17604580.
  2. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res. 2008;23(1):143-50. doi: 10.1359/jbmr.071003, PMID 17907920.
  3. Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005;35(5):290-304. doi: 10.1111/j.1365-2362.2005.01487.x, PMID 15860041.
  4. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662-87. doi: 10.1210/er.2004-0002, PMID 15798098.
  5. Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2010;55(9):2624-8. doi: 10.1007/s10620-009-1069-9, PMID 19960254.
  6. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. doi: 10.1056/NEJMra070553, PMID 17634462.
  7. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets. 2011;12(1):4-18. doi: 10.2174/138945011793591635, PMID 20795941.
  8. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771-7. doi: 10.1016/s8756-3282(02)00692-0, PMID 11996918.
  9. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol. 2007;5(4):513-20. doi: 10.1016/j.cgh.2006.10.015, PMID 17222588.
  10. Putz-Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M et al. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int. 2012;32(5):845-51. doi: 10.1111/j.1478-3231.2011.02735.x, PMID 22222013.
  11. Kishan Gupta B, Lal Saini M, Ram Nehara H, Lal Meena S, Saini M, Gupta J. Evaluation of vitamin D deficiency in patients with chronic liver disease and its clinical significance. Int J Nutr. 2016;2(2):29-35. doi: 10.14302/issn.2379-7835.ijn-16-1381.
  12. Silva MC, Furlanetto TW. Intestinal absorption of vitamin D: a systematic review. Nutr Rev. 2018 Jan 1;76(1):60-76. doi: 10.1093/nutrit/nux034, PMID 29025082.
  13. Arora I, Gupta V, Benjamin J, Upadhaya A, Rashid S, Saraya A. To study the prevalence of vitamin D deficiency and osteoporosis in patients of chronic liver disease according to their child status. J Clin Exp Hepatol. 2015 Jun 1;5:S31-2. doi: 10.1016/j.jceh.2015.07.214.
  14. Sharma DN, Prakash DS, Arora DI. Study of vitamin D levels and its correlation with child PUGH score in patients of chronic liver disease. Study of vitamin D levels and its correlation with child PUGH score in patients of chronic liver disease. Int J Adv Res Med. 2021;3(1):323-7. doi: 10.22271/27069567.2021.v3.i1f.158. Int J Adv Res Med 2021;3(1):323-327.
  15. Mavi K, Kumar A, Singh V, Krishna H. Estimation of vitamin D level in patients of chronic liver disease and its association with child Turcotte Pugh’s score. Acad J Med. 2021;4(1):21-6.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© 2009-2025 IJPBS, India. All rights reserved. Specialized online journals by ubijournal | Home | Contact | Terms & Conditions